News & analysis

May has been a decisive month in the global vaccination campaign, as an accelerated delivery in some advanced economies has led to comprehensive reopening plans and brighter economic prospects. In Europe and Canada, two significant laggards in Q1 compared to the UK and the US, the intake of vaccines has exceeded expectations. However, while advanced economies have managed to secure enough doses to kick-off domestic vaccinations earlier, most emerging markets and low-income countries have failed to sign significant contracts in the first half of the year. Wide divergences in national vaccination campaigns is a matter of global concern from a health standpoint, as uneven immunisation worldwide poses the risk of further waves in the context of relaxed travel restrictions. Divergences between countries in terms of vaccination is also critical from an economic point of view, as vaccination constraints set the tone for bumpy reopening plans. Under this light, risks to the global outlook remain tilted to the downside, even as developed countries pledge to expand their contribution to economies at an earlier stage of vaccinations.

Read our Vaccine Distribution Chartbook report in full here:

DOWNLOAD THE FULL REPORT

 

Disclaimer
This information has been prepared by Monex Europe Limited, an execution-only service provider. The material is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is, or should be considered to be, financial, investment or other advice on which reliance should be placed. No representation or warranty is given as to the accuracy or completeness of this information. No opinion given in the material constitutes a recommendation by Monex Europe Limited or the author that any particular transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research, it is not subject to any prohibition on dealing ahead of the dissemination of investment research and as such is considered to be a marketing communication.